Keros Therapeutics Stock Forecast - Simple Regression
KROS Stock | USD 57.74 0.81 1.38% |
The Simple Regression forecasted value of Keros Therapeutics on the next trading day is expected to be 60.79 with a mean absolute deviation of 2.56 and the sum of the absolute errors of 155.88. Keros Stock Forecast is based on your current time horizon.
Keros |
Keros Therapeutics Simple Regression Price Forecast For the 30th of November
Given 90 days horizon, the Simple Regression forecasted value of Keros Therapeutics on the next trading day is expected to be 60.79 with a mean absolute deviation of 2.56, mean absolute percentage error of 10.88, and the sum of the absolute errors of 155.88.Please note that although there have been many attempts to predict Keros Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Keros Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Keros Therapeutics Stock Forecast Pattern
Backtest Keros Therapeutics | Keros Therapeutics Price Prediction | Buy or Sell Advice |
Keros Therapeutics Forecasted Value
In the context of forecasting Keros Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Keros Therapeutics' downside and upside margins for the forecasting period are 58.05 and 63.53, respectively. We have considered Keros Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Keros Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Keros Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.AIC | Akaike Information Criteria | 120.4971 |
Bias | Arithmetic mean of the errors | None |
MAD | Mean absolute deviation | 2.5554 |
MAPE | Mean absolute percentage error | 0.0432 |
SAE | Sum of the absolute errors | 155.877 |
Predictive Modules for Keros Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Keros Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Other Forecasting Options for Keros Therapeutics
For every potential investor in Keros, whether a beginner or expert, Keros Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Keros Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Keros. Basic forecasting techniques help filter out the noise by identifying Keros Therapeutics' price trends.View Keros Therapeutics Related Equities
Risk & Return | Correlation |
Keros Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Keros Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Keros Therapeutics' current price.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Keros Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Keros Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Keros Therapeutics shares will generate the highest return on investment. By undertsting and applying Keros Therapeutics stock market strength indicators, traders can identify Keros Therapeutics entry and exit signals to maximize returns.
Accumulation Distribution | 3670.28 | |||
Daily Balance Of Power | (0.47) | |||
Rate Of Daily Change | 0.99 | |||
Day Median Price | 58.11 | |||
Day Typical Price | 57.99 | |||
Price Action Indicator | (0.77) | |||
Period Momentum Indicator | (0.81) | |||
Relative Strength Index | 77.29 |
Keros Therapeutics Risk Indicators
The analysis of Keros Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Keros Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting keros stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Mean Deviation | 2.09 | |||
Semi Deviation | 2.19 | |||
Standard Deviation | 2.76 | |||
Variance | 7.64 | |||
Downside Variance | 6.37 | |||
Semi Variance | 4.79 | |||
Expected Short fall | (2.25) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Keros Stock Analysis
When running Keros Therapeutics' price analysis, check to measure Keros Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Keros Therapeutics is operating at the current time. Most of Keros Therapeutics' value examination focuses on studying past and present price action to predict the probability of Keros Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Keros Therapeutics' price. Additionally, you may evaluate how the addition of Keros Therapeutics to your portfolios can decrease your overall portfolio volatility.